Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs PNC Financial Services Group Inc. (The) Common Stock (PNC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs PNC Financial Services Group Inc. (The) Common Stock — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.98 (market cap $31.07B), while PNC Financial Services Group Inc. (The) Common Stock trades at $216.16 (market cap $86.09B). The key difference: PNC Financial Services Group Inc. (The) Common Stock is far larger — about 2.8× GE HealthCare Technologies Inc. Common Stock's market cap, and PNC Financial Services Group Inc. (The) Common Stock pays the higher dividend (3.71%). Which is the better fit depends on your goals.
| GEHC | PNC | |
|---|---|---|
Market Cap | $31.07B | $86.09B |
Volume | 3,443,020 | 3,223,582 |
Sector | Health | Financials |
52-Week High | $88.16 | $256.97 |
52-Week Low | $59.48 | $178.37 |
Enterprise Value | $39.53B | $143.07B |
Dividend Yield | 0.23% | 3.71% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
PNC trades at $219.48, down 0.8% on the day, with a bearish technical signal but strong fundamentals. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results expected soon. Revenue grew to $23.08B in 2025, with net income of $6.94B and a robust net income margin of 31.06%. Analyst consensus is a Buy with a $276.13 price target, indicating significant upside potential from current levels.
The outlook for PNC is positive given its earnings momentum and attractive valuation (P/E of 12.09), though risks include regulatory scrutiny and net cash outflows from investing activities. The stock offers a dividend yield supported by recent increases, positioning it as a value opportunity in the financial sector amid current bearish technical indicators.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About PNC Financial Services Group Inc. (The) Common Stock
PNC Financial Services Group is a financial services holding company. Its businesses include retail banking, corporate and institutional banking, and asset management.
Read more on PNC →
